Moral enhancement

Journal of Applied Philosophy

Volumn 25, Issue 3, 2008, Pages 228-245

  Douglas, Thomas ^a  

^a CHRIST CHURCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57749142260     PISSN: 02643758     EISSN: 14685930     Source Type: Journal    
DOI: 10.1111/j.1468-5930.2008.00412.x     Document Type: Article

References (44)

1. M. Verroken, ‘Drug use and abuse in sport’, in D. R. Mottram (ed.) Drugs in Sport (London: Routledge, 2005), pp. 29-63.
2. B. Tindall, ‘Better playing through chemistry’, New York Times, 17. Oct 2004.
3. L. D. Johnston, P. M. O’Malley & J. G. Bachman, Monitoring the Future National Survey Results on Drug Use, 1975-2002: II. College Students and Adults Ages 19-40 (Washington DC: US Department of Health and Human Services, 2003)
4. C. J. Teter, S. E. McCabe, K. LaGrange et al., ‘Illicit use of specific stimulants among college students: prevalence, motives, and routes of administration’, Pharmacotherapy, 26, 10 (2006): 1501-1510.
5. G. Lynch, ‘Memory enhancement: the search for mechanism-based drugs’, Nature Neuroscience 5 (2002): 1035-1038
6. R. Scott, R. Bourtchouladze, S. Gossweiler et al., ‘CREB and the discovery of cognitive enhancers’, Journal of Molecular Neuroscience 19 (2002) 171-177
7. T. Tully, R. Bourtchouladze, R. Scott et al., ‘Targeting the CREB pathway for memory enhancers’, Nature Reviews Drug Discovery 2 (2003): 267-277.
8. J. Yesavage, M. Mumenthaler, J. Taylor et al., ‘Donezepil and flight simulator performance: effects on retention of complex skills’, Neurology 59 (2001): 123-125.
9. J. A. Caldwell, J. L. Caldwell & N. K. Smythe, ‘A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study’, Psychopharmacology 150 (2000): 272-282
10. D. C. Turner, T. W. Robbins, L. Clark, A. R. Aron, J. Dowson & B. J. Sahakian, ‘Cognitive enhancing effects of modafinil in healthy volunteers’, Psychopharmacology 165 (2003): 260-269.
11. M. J. Sandel, ‘The case against perfection’, The Atlantic Monthly 293, 3 (2004): 50-65
12. The Case Against Perfection: Ethics in the Age of Genetic Engineering (Cambridge, MA: Harvard University Press, 2007) esp. at pp. 12, 47-49.
13. G. A. Annas, ‘Cell division’, Boston Globe, 21. April 2002
14. F. Fukuyama, Our Posthuman Future: Consequences of the Biotechnology Revolution (New York: Farrar, Straus, and Giroux, 2002), p. 97
15. B. McKibben, ‘Designer genes’, Orion, 30. April 2003
16. M. J. Mehlman, ‘Genetic enhancement: plan now to act later’, Kennedy Institute of Ethics Journal 15, 1 (2005): 77-82.
17. A. Buchanan, D. Brock, N. Daniels & D. Wikler, From Chance to Choice: Genetics and Justice (Cambridge: Cambridge University Press, 2000), pp. 188-191
18. McKibben (2003) 188-191
19. M. J. Farah, J. Illes, R. Cook-Deegan et al., ‘Neurocognitive enhancement: what can we do and what should we do?’ Nature Reviews Neuroscience 5 (2004): 421-425 at p. 423
20. Sandel (2007) Neurocognitive enhancement: what can we do and what should we do?’ Nature Reviews Neuroscience 5 (2004)., pp. 8-12
21. Sandel (2007) Neurocognitive enhancement: what can we do and what should we do?’ Nature Reviews Neuroscience 5 (2004)., p. 15. 10.
22. Critique of Practical Reason, 3rd edn., L. W. Beck, trans. (New York: Macmillan, 1993) Book I, Chapter I.
23. J. S. Mill, Utilitarianism G. Sher, ed. (Indianapolis: Hackett, 1979), pp. 27-28.
24. Nicomachean Ethics, T. Irwin, trans. (Indianapolis: Hackett, 1985).
25. Antonio Damasio, Descartes’ Error: Emotion, Reason and the Human Brain (London, Vintage, 2006).
26. Nelen, P. van Zandvoort et al., ‘X-linked borderline mental retardation with prominent behavioural disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism’, American Journal of Human Genetics, 52, 6 (1993): 1032-1039.
27. A. Caspi & J. McClay, ‘Evidence that the cycle of violence in maltreated children depends on genotype’, Science 297 (2002): 851-854
28. R. M. M. de Almeida, P. F. Ferari, S. Parmigiani et al., ‘Escalated aggressive behavior: Dopamine, serotonin and GABA’, European Journal of Pharmacology 526 (2005): 51-64.
29. A. J. Hart, P. J. Whalen, L. M. Shin et al., ‘Differential response in the human amygdala to racial outgroup vs. ingroup face stimuli’, Neuroreport: For Rapid Communication of Neuroscience Research 11 (2000): 2351-2355
30. E. A. Phelps, K. J. O’Connor, W. A. Cunningham et al., ‘Performance on indirect measures of race evaluation predicts amygdala activation’, Journal of Cognitive Neuroscience 12 (2000): 729-738
31. W. A. Cunningham, M. K. Johnson, C. L. Raye et al., ‘Separable neural components in the processing of black and white faces’, Psychological Science 15 (2004): 806-813.
32. Sandel (2004), pp. 50-65
33. Sandel (2007)
34. L. R. Kass, ‘Ageless bodies, happy souls: biotechnology and the pursuit of perfection’, The New Atlantis 1 (2003): 9-28 at pp. 21-24
35. President’s Council on Bioethics, Beyond Therapy: Biotechnology and the Pursuit of Happiness (Washington DC: President’s Council on Bioethics, 2003) at pp. 290-293.
36. Kass (2003), pp. 17, 20-24
37. President’s Council on Bioethics (2003), pp. 290-293.
38. D. Hume, A Treatise of Human Nature, L. A. Selby-Bigge, ed. (Oxford: Clarendon, 1888), pp. 473-475.
39. G. E. Moore, Principia Ethica (Cambridge: Cambridge University Press, 1903), p. 92.
40. Kass (2003), pp. 22-24.
41. D. Heyd, ‘Human nature: an oxymoron?’ Journal of Medicine and Philosophy 28, 2 (2003): 151-169 at pp. 156-157.
42. P. R. Wolpe, ‘Treatment, enhancement, and the ethics of neurotherapeutics’, Brain and Cognition 50 (2002): 387-395 at pp. 393-394
43. M. Schechtman, The Constitution of Selves (Ithaca, NY: Cornell University Press, 1996), esp. at pp. 74-76.
44. C. Taylor, ‘What’s wrong with negative liberty’ in A. Ryan (ed.) The Idea of Freedom (London, Oxford University Press, 1979), pp. 175-193.